Wagner, Verena
Gil, Jesús http://orcid.org/0000-0002-4303-6260
Funding for this research was provided by:
Cancer Research UK (C15075/A28647, C15075/A28647)
RCUK | Medical Research Council (MC_U120085810, MC_U120085810)
German Cancer Aid Mildred- Scheel-Postdoc Program
Article History
Received: 28 April 2020
Revised: 26 May 2020
Accepted: 3 June 2020
First Online: 15 June 2020
Compliance with ethical standards
:
: JG has acted as a consultant for Unity Biotechnology and Geras Bio and Merck KGaA, owns equity in Unity Biotechnology and Geras Bio, and is a named inventor in an MRC patent related to senolytic therapies.